In addition, the result of IHC also revealed that the PRMT5 expression was remarkably stronger in ESCC tissues than the control tissues, while the result of immunofluorescence confirmed that PRMT5 was overexpressed in the ESCC cell lines (Figure 1G). The gene discussed is PRMT5; the disease is esophageal squamous cell carcinoma.